BRCA1 and breast cancer: This approach could help identify more patients with hereditary cancers; approximately 9% of patients with breast cancer who had tested negative for BRCA1/2 mutations and underwent subsequent panel testing were found to have a pathogenic mutation in a breast cancer susceptibility gene [49].